6-Chloropurine Riboside>97.0%(HPLC)(T)1g

4-(2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-yl)aniline, 95.0%, 2g

1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxamide, 95.0%, 10g

4-(6-Chloro-3-pyridazinyl)morpholine, 95.0%, 5g

Potassium carbonate, ROTI®METIC 99.995% (4N5), 10 g, plastic packaging.

GC capillary column ROTI®Cap-1701, 25 m, 0.32 mm, 0.50 µm, 1 Piece(s)

(2E)-1-(2-methoxyphenyl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one, 95.0%, 2g

Tert-butyl-dimethyl-pent-4-ynoxy-silane, 98%, 25g

2-Methyl-1H-imidazole-4,5-dicarboxylic acid diethyl ester, 95.0%, 1g

Ethyl 2-aminohex-5-enoate, 98%, 1g

Bromodifluoroacetic acid, 97.00%, 100g

5-bromo-1,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 95.0%, 1g

Ethyl 3-(((trifluoromethyl)sulfonyl)oxy)furo[2,3-c]pyridine-2-carboxylate, 95.0%, 250mg